High incidence of peripheral blood plasmacytosis in patients with dengue virus infection

Clinical Microbiology and Infection

Volumn 17, Issue 12, 2011, Pages 1823-1828

  Thai, K T D ^a,b   Wismeijer, J A ^a   Zumpolle, C ^a   de Jong, M D ^a,b   Kersten, M J ^a   de Vries, P J ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cluster of differentiation; Dengue; Kinetics; Plasma cells; The Netherlands

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ARTICLE; CELL KINETICS; CELL STRUCTURE; CLINICAL ARTICLE; DENGUE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION; MALE; MORBIDITY; PLASMA CELL; PLASMACYTOSIS; PRIORITY JOURNAL; VIRUS LOAD;

DENGUE VIRUS;

EID: 81255138199     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03434.x     Document Type: Article

References (29)

1. Jessie K, Fong MY, Devi S, Lam SK, Wong KT. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 2004; 189: 1411-1418.
2. Dengue: guidelines for diagnosis, treatment, prevention and control - New edition. World Health Organization and the Special Programme for Research and Training in Tropical Diseases; 2009.
3. La Russa VF, Innis BL. Mechanisms of dengue virus-induced bone marrow suppression. Baillieres Clin Haematol 1995; 8: 249-270.
4. Bibi-Triki T, Aras N, Braun T et al. [Peripheral and bone marrow plasmacytosis in dengue fever: report of a case]. Rev Med Interne 2009; 30: 274-276.
5. Gawoski JM, Ooi WW. Dengue fever mimicking plasma cell leukemia. Arch Pathol Lab Med 2003; 127: 1026-1027.
6. Jego G, Robillard N, Puthier D et al. Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells. Blood 1999; 94: 701-712.
7. Koduri PR, Naides SJ. Transient blood plasmacytosis in parvovirus B19 infection: a report of two cases. Ann Hematol 1996; 72: 49-51.
8. Komiya I, Saito Y, Kuriya S. Peripheral blood plasmacytosis in a patient with infectious mononucleosis-like illness. Eur J Haematol 1991; 46: 61-62.
9. Pellat-Deceunynck C, Jego G, Robillard N et al. Reactive plasmacytoses, a model for studying the biology of human plasma cell progenitors and precursors. Hematol J 2000; 1: 362-366.
10. Poje EJ, Soori GS, Weisenburger DD. Systemic polyclonal B-immunoblastic proliferation with marked peripheral blood and bone marrow plasmacytosis. Am J Clin Pathol 1992; 98: 222-226.
11. Shtalrid M, Shvidel L, Vorst E. Polyclonal reactive peripheral blood plasmacytosis mimicking plasma cell leukemia in a patient with Staphylococcal sepsis. Leuk Lymphoma 2003; 44: 379-380.
12. Boom R, Sol C, Beld M et al. Improved silica-guanidiniumthiocyanate DNA isolation procedure based on selective binding of bovine alpha-casein to silica particles. J Clin Microbiol 1999; 37: 615-619.
13. Laue T, Emmerich P, Schmitz H. Detection of dengue virus RNA in patients after primary or secondary dengue infection by using the TaqMan automated amplification system. J Clin Microbiol 1999; 37: 2543-2547.
14. Innis BL, Nisalak A, Nimmannitya S et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg 1989; 40: 418-427.
15. Schilling S, Ludolfs D, Van AL, Schmitz H. Laboratory diagnosis of primary and secondary dengue infection. J Clin Virol 2004; 31: 179-184.
16. Calame KL, Lin KI, Tunyaplin C. Regulatory mechanisms that determine the development and function of plasma cells. Annu Rev Immunol 2003; 21: 205-230.
17. Harada Y, Kawano MM, Huang N et al. Identification of early plasma cells in peripheral blood and their clinical significance. Br J Haematol 1996; 92: 184-191.
18. Laferl H, Szell M, Bischof E, Wenisch C. Imported dengue fever in Austria 1990-2005. Travel Med Infect Dis 2006; 4: 319-323.
19. Wichmann O, Hongsiriwon S, Bowonwatanuwong C et al. Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand. Trop Med Int Health 2004; 9: 1022-1029.
20. Jampangern W, Vongthoung K, Jittmittraphap A et al. Characterization of atypical lymphocytes and immunophenotypes of lymphocytes in patients with dengue virus infection. Asian Pac J Allergy Immunol 2007; 25: 27-36.
21. Dalakas MC. B cells as therapeutic targets in autoimmune neurological disorders. Nat Clin Pract Neurol 2008; 4: 557-567.
22. Caraux A, Klein B, Paiva B et al. Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal C. Haematologica 2010; 95: 1016-1020.
23. Hober D, Poli L, Roblin B et al. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am J Trop Med Hyg 1993; 48: 324-331.
24. Huang YH, Lei HY, Liu HS et al. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg 2000; 63: 71-75.
25. Akira S, Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J 1990; 4: 2860-2867.
26. Klein B, Zhang XG, Jourdan M et al. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma. Eur Cytokine Netw 1990; 1: 193-201.
27. Chang DM, Shaio MF. Production of interleukin-1 (IL-1) and IL-1 inhibitor by human monocytes exposed to dengue virus. J Infect Dis 1994; 170: 811-817.
28. Juffrie M, Meer GM, Hack CE et al. Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2. Am J Trop Med Hyg 2001; 65: 70-75.
29. Levy A, Valero N, Espina LM et al. Increment of interleukin 6, tumour necrosis factor alpha, nitric oxide, C-reactive protein and apoptosis in dengue. Trans R Soc Trop Med Hyg 2010; 104: 16-23.